Orthopedic surgery or orthopedics (also spelled orthopaedics) is the branch of surgery concerned with conditions involving the musculoskeletal system. Orthopedic surgeons use both surgical and non-surgical means to treat musculoskeletal trauma, sports injuries, degenerative diseases, infections, tumors, and congenital conditions.
Ascension Orthopedics, Inc., a leader in orthopedic extremity implants, announces the international market launch of the PyroTITAN™ Humeral Resurfacing Arthroplasty System at the American Academy of Orthopaedic Surgeons Annual Conference in New Orleans, LA, March 9-13, 2010. Designed to meet the unique soft tissue biocompatibility requirements of the shoulder joint, the PyroTITAN humeral resurfacing implant is the first commercially-available, human shoulder arthroplasty prosthesis made of PyroCarbon.
Acologix, Inc., a privately held biopharmaceutical company, today announced the results of its latest preclinical study demonstrating that AC-100, its therapeutic product candidate derived from an endogenous human protein, promotes cartilage regeneration in a large animal model. The data will be presented by Dr. David M. Rosen on March 6, 2010 at the 56th annual meeting of the ORS in New Orleans, LA.
MedShape Solutions announced today that it is pursuing Phase III SBIR awards and has received preferred vendor status at Veterans Health Administration Hospitals and other Federally funded hospitals for its MORPHIX ™ Shape Memory Suture Anchor.
Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company and Pfizer Inc., was statistically superior to 40 mg once daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total knee replacement surgery, according to the ADVANCE-2 study results published today in The Lancet. The study results also showed numerically lower rates of major and clinically relevant non-major bleeding in patients treated with apixaban compared with those treated with enoxaparin.
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it has entered into a sponsored research agreement (SRA) with the University of Michigan to evaluate bone defect repairs using human stem cells. The one-year project, beginning in March, will be funded through the proceeds of a $108,746 grant from the National Institutes of Health (NIH) under the Small Business Innovative Research Program (SBIR).
Kansas Health Institute: "Republicans and Democrats were sharply divided Tuesday over a proposed constitutional amendment that sponsors said would let federal officials know Kansans don't want to be told by the government that they must buy health insurance. On a 12-9, party-line vote, the House Health and Human Services Committee voted to recommend House Concurrent Resolution 5032 favorable for passage.
OrthoDynamix announced today that it has received FDA clearance for its new device, ArthroSteer 3.5mm Ablator, a mono polar electrosurgical device, for general surgical use, including the orthopedic and arthroscopic applications for resection, ablation, excision of soft tissue, hemostasis of blood vessels, and coagulating soft tissue in, but not limited to the knee, shoulder, and primarily the hip.
(U.S. Physical Therapy) The American Physical Therapy Association (APTA) reported on its website (APTA.org) on Friday, February 26, 2010 that “The Centers for Medicare and Medicaid Services (CMS) announced that it will hold claims for the first 10 business days of March. The hold will apply to claims with dates of service of March 1, 2010 through March 12, 2010. Claims with dates of service of January 1, 2010-February 28, 2010 will continue to be paid based on the 0% update approved by Congress.
U.S. Physical Therapy, Inc., a leading national operator of outpatient physical and occupational therapy clinics, has acquired a 70% interest in a five clinic outpatient physical therapy group. The practice presently has more than 58,000 patient visits per year and produces approximately $6.9 million in annual revenue.
Baxter International Inc., a global, diversified healthcare company, and ApaTech, a private equity-backed, U.K.-based orthobiologic products company, today announced a definitive agreement whereby Baxter will acquire all of the outstanding equity of ApaTech for total consideration of up to $330 million.
MiMedx Group, Inc. announced today that the Company received the CE Mark for its HydroFix™ Spine Shield device and was certified for design, development, and production of post-surgical adhesion inhibiting barriers.
Aurora BayCare will host a statewide meeting Friday, March 5, to promote the development of medical technology businesses in northeastern Wisconsin. The "Medical Device Collaboration Gathering" will take place at Aurora BayCare Orthopedic & Sports Medicine Center, 1160 Kepler Drive in Green Bay.
On Feb. 22, the day after America watched some of its strongest hearts compete in Vancouver on the 30th anniversary of the “Miracle on Ice” hockey game, a lucky patient at El Camino Hospital was recuperating from his own miracle.
Musculoskeletal Imaging Consultants announces release of “Inside Business with Fred Thompson” documentary. MSKIC accomplishes Obama challenge of “more for less” by leveraging technology and bypassing obstructions to health information sharing.
A paper published online today in Molecular Cell proposes that Methyl CpG binding protein 2 (MeCP2) impacts the entire genome in neurons, rather than acting as a regulator of specific genes. Mutations in MeCP2 cause the autism spectrum disorder Rett Syndrome as well as some cases of neuropsychiatric problems including autism, schizophrenia and learning disabilities.
As many as half of all women and a quarter of men over the age of 50 can expect to sustain a fractured bone related to osteoporosis or low bone density. To enhance prevention and treatment of these fragility fractures, NewYork-Presbyterian Hospital/Columbia University Medical Center has implemented an innovative program called Own the Bone™ developed by the American Orthopaedic Association.
Symmetry Medical Inc., a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced fourth quarter and full year 2009 financial results for the period ended January 2, 2010.
“Patients receiving Prochymal did better than those receiving only standard-of-care,” said Dr. Hare, lead author of the JACC publication.
Wright State University Boonshoft School of Medicine and Miami Valley Hospital announced today the formation of the Wright State University & Premier Health Partners Neuroscience Institute to speed the transfer of research discoveries from bench to bedside, improving the diagnosis and treatment of neurological disorders such as stroke. Ohio Governor Ted Strickland and Chancellor of the Ohio Board of Regents Eric Fingerhut joined Wright State University and Miami Valley Hospital officials in making the announcement.
Implantable Provider Group is pleased to announce a significant agreement with Blue Cross and Blue Shield of Florida, Inc. to be its designated implantable device management vendor for its extensive provider network. IPG will handle device coordination, billing, replacement, tracking, and other services for BCBSF’s statewide ambulatory surgery center (ASC) network.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.